Prostate cancer gene map points way to targeted drugs

  • 21 May 2015
  • From the section Health
Prostate cancer
The study suggests nearly nine in 10 patients with advanced prostate cancer could benefit from targeted treatments

Scientists have unveiled a comprehensive genetic map of advanced prostate cancer, hailing it as the disease's "Rosetta Stone".

The study, published in the journal Cell, shows that nearly nine in 10 men had gene mutations that could be targeted with drugs.

The study was led in the UK by scientists at the Institute of Cancer Research (ICR) London in collaboration with several teams in the United States.

Researchers analysed the genetic codes of tumours from 150 patients with metastatic - or advanced - prostate cancer, whose disease had spread to other parts of the body.

They found that 89% had genetic aberrations for which there were existing drugs or treatments undergoing clinical trials.

Read full article Prostate cancer gene map points way to targeted drugs

Call for $2bn global antibiotic research fund

  • 14 May 2015
  • From the section Health
Bacteria
Some bacteria are becoming resistant to our best drugs

The global pharmaceutical industry is being called on to pay for a $2bn (£1.3bn) innovation fund to revitalise research into antibiotics.

In return, there would be guaranteed payments to companies which produced vitally needed new antibiotics.

Read full article Call for $2bn global antibiotic research fund

Europe's first non-beating heart transplant

  • 26 March 2015
  • From the section Health

Surgeons in Cambridgeshire have performed the first heart transplant in Europe using a non-beating heart.

Donor hearts are usually from people who are brain-stem dead, but whose hearts are still beating.

Read full article Europe's first non-beating heart transplant

'I'm 39 and have Alzheimer's disease'

  • 11 March 2015
  • From the section Health
Chris Graham
Chris Graham has inherited a gene which causes early onset Alzheimer's

To outward appearances Chris Graham is a fit and apparently healthy 39-year-old.

But the former soldier also has early onset Alzheimer's disease.

Read full article 'I'm 39 and have Alzheimer's disease'

Defeating cancer, the 'evil genius'

  • 11 February 2015
  • From the section Health
Sophie Armitage
Sophie Armitage has been described by her consultant as a miracle child

"If you had to describe cancer I would say it's an evil genius."

It's a vivid metaphor from Dr Udai Banerji, of the Institute of Cancer Research and the Royal Marsden, for the challenge facing patients, scientists and clinicians.

Read full article Defeating cancer, the 'evil genius'

Paralysed man who walked again visits the UK

  • 1 February 2015
  • From the section Health
Darek
Darek Fidyka at the Emirates stadium

"I feel proud and honoured to be here." Darek Fidyka's words to me as he waited to form part of the guard of honour for the players at the Emirates stadium where Arsenal were about to face Aston Villa.

Paralysed from the chest down in a knife attack, Darek, from Poland, was the first person in the world to undergo a pioneering treatment which has enabled him to walk again with the aid of a frame.

Read full article Paralysed man who walked again visits the UK

Ebola trial suggests vaccine is safe

  • 28 January 2015
  • From the section Health

The first results of an experimental Ebola vaccine being tested in Oxford suggest it is safe.

Sixty healthy volunteers were immunised at the University of Oxford's Jenner Institute.

Read full article Ebola trial suggests vaccine is safe

Ebola: New vaccine trial begins

  • 6 January 2015
  • From the section Health
Ebola vaccine
Volunteers will receive two doses of the test vaccine

Scientists at Oxford University have begun immunising healthy volunteers with a new Ebola vaccine.

In September last year a separate trial of another Ebola vaccine got under way in the city.

Read full article Ebola: New vaccine trial begins

Superbugs to kill 'more than cancer' by 2050

  • 11 December 2014
  • From the section Health
bacteria
Drug resistant E.coli bacteria are already a significant problem in Europe

Drug resistant infections will kill an extra 10 million people a year worldwide - more than currently die from cancer - by 2050 unless action is taken, a study says.

They are currently implicated in 700,000 deaths each year.

Read full article Superbugs to kill 'more than cancer' by 2050

Ebola vaccine 'promising' say scientists after human trial

  • 26 November 2014
  • From the section Health
Vaccine injection
A 39-year-old woman was the first volunteer to receive the experimental Ebola vaccine

The first human trial of an experimental vaccine against Ebola suggests that it is safe and may help the immune system to combat the virus.

Twenty volunteers were immunised in the United States. Scientists at the US National Institutes of Health (NIH) described the results as "promising".

Read full article Ebola vaccine 'promising' say scientists after human trial